Non-precipitating bodily fluid analysis system
View Patent ↗A bodily fluid analyzer including a dry test strip impregnated with a reagent providing a non-precipitating reaction to exclude non-desired analytes. The reagent complexes the non-desired analytes so they remain in solution but cannot participate in the test reaction. Red blood cells are removed from the detection area by slowing their vertical movement and stopping flow when the detection membrane is saturated.
1. A method of determining a characteristic of high density lipoprotein (HDL) from a plurality of analytes in a bodily fluid, said method comprising:
providing said bodily fluid containing HDL and one or more non-selected analytes;
providing a dry test strip having a well with porous layers within said well that allow said analytes to pass creating a vertical column of said analytes having a defined volume;
applying said bodily fluid to said well in said dry test strip; and
reacting HDL in the bodily fluid with a reactant in said dry test strip to provide an indication of said characteristic while preventing said one or more non-selected analytes from participating in said reaction, without precipitating said one or more non-selected analytes.
2. A method as in claim 1 wherein said bodily fluid is blood.
3. A method as in claim 2 wherein said characteristic comprises the concentration of said high density lipoproteins in said blood.
4. A method as in claim 2 wherein said one or more non-selected analytes are selected from the group consisting of analytes, such as LDL (low density lipoproteins), VLDL (very low density lipoproteins), ILDL (intermediate density lipoproteins), and chylomicrons (big, tryglyceride-rich lipoproteins).
5. A method as in claim 1 wherein said indication is an optical indication.
6. A method as in claim 5 wherein said optical indication is a colorimetric indication.
7. A method as in claim 1 wherein said preventing comprises complexing said non-selected analyte so that it cannot participate in said reaction.
8. A method as in claim 7 wherein said complexing comprises interacting said non-selected analytes with a polyanion.
9. A method as in claim 8 wherein said polyanion is an anionic polymer.
10. A method as in claim 9 wherein said anionic polymer has a molecular weight between 50,000 and 8,000.
11. A method as in claim 9 wherein said anionic polymer has a molecular weight between 25,000 and 10,000.
12. A method as in claim 9 wherein said anionic polymer has a molecular weight between 18,000 and 12,000.
13. A method as in claim 9 wherein said anionic polymer comprises dextran sulphate.
14. A method as in claim 9 wherein said reacting further comprises reacting with a divalent metal.
15. A method as in claim 7 wherein said complexing comprises exposing said non-selected analyte to a reagent comprising dextran sulphate and a divalent metal.
16. A method as in claim 1 wherein said preventing further comprises flowing said complexed non-selected analytes through an asymmetric membrane to slow their flow.